Isaac Perlmutter is Israeli American, born in Israel on December 1, 1942. His primary source of wealth (and certainly what he’s most famous for) is Marvel Entertainment.
According to Forbes, Permutter has an estimated net worth of $3.8 billion. He has been the Chief Executive Officer for Marvel Entertainment since January 1, 2005. He also owns Toy Biz and Remington Products.
Perlmutter came to the US as an Israeli immigrant with only $250. As a veteran of the Israel’s 1967 Six-Day War, he presided over the funerals of Jewish in Brooklyn. Then he turned to the business world and got into the toy business
He formed Odd Lot Trading Company collaborating with Bernard Marden, a company that specialized in retailing and wholesaling closeout items. Odd Lot Trading was sold to Revco Discount Drug Stores in exchange for a 12% Revco stock in 1984. Shortly afterward, Marden’s and Perlmutter’s shares of Revco were sold for $120 million.
Isaac Perlmutter acquired the controlling interest of Victor Kiam to Remington Products in 1994 and became Vice President of Remington. Perlmutter and Kiam sold Remington Products to Vestar Capital Partners in 1996.
In October 1998, he took over the control of bankrupt Marvel which was owned at the time by billionaire Ron Perelman. In 2009, Perlmutter sold most of Marvel to Disney for $4 billion in cash and stock, and he still occupies the position of CEO of the company.
Marvel CEO Isaac “Ike” Perlmutter is the one behind some of the greatest movies in the last ten years, which included “Guardians of the Galaxy”, “Iron Man”, and “Avengers 2”. Even if you don’t agree with the Hollywood/Marvel movie machine, there’s no denying that the Marvel comics movies have been hugely successful and there have been plenty of awesome films to offset the not so great ones.
In December 2013, he and wife Laura pledged more than $50 million to create the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center. In 2015, they donated $9 million to a collaborative cancer research program between Technion-Israel Institute of Technology and NYU Langone Medical Center.
